# A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects

> **NCT00053378** · PHASE2 · COMPLETED · sponsor: **Abbott** · enrollment: 45 (—)

## Conditions studied

- Hypocalcemia

## Interventions

- **DRUG:** paricalcitol injection (Zemplar)
- **BEHAVIORAL:** Effects on calcium regulation
- **BEHAVIORAL:** Administration of elemental Ca during hypocalcemic ICU pts.

## Key facts

- **NCT ID:** NCT00053378
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-01
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 45 (—)
- **Last updated:** 2006-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00053378

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00053378, "A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00053378. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*